Pacira Biosciences, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6951271005
USD
23.98
-0.09 (-0.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
700.97
674.98
666.82
541.53
429.65
421.03
337.28
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
700.97
674.98
666.82
541.53
429.65
421.03
337.28
Raw Material Cost
227.72
241.96
256.58
153.81
125.19
112.42
86.84
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.57
20.31
39.98
31.75
25.67
23.63
21.95
Selling and Distribution Expenses
294.10
269.44
254.52
199.34
193.52
200.78
170.16
Other Expenses
6.50
5.60
4.48
2.38
3.38
4.85
3.37
Total Expenditure (Excl Depreciation)
603.39
587.65
595.90
408.70
378.13
385.32
312.70
Operating Profit (PBDIT) excl Other Income
97.6
87.30000000000001
70.9
132.79999999999998
51.5
35.699999999999996
24.6
Other Income
19.32
11.26
-6.75
-1.77
11.58
8.10
5.61
Operating Profit (PBDIT)
195.68
174.15
155.68
159.61
83.00
63.39
43.35
Interest
16.57
20.31
39.98
31.75
25.67
23.63
21.95
Exceptional Items
-163.43
-16.57
-10.90
-42.91
-17.34
-30.93
-8.66
Gross Profit (PBDT)
473.25
433.02
410.24
387.73
304.45
308.61
250.43
Depreciation
78.78
75.57
91.50
28.55
19.91
19.58
13.16
Profit Before Tax
-63.11
61.70
13.30
56.40
20.09
-10.75
-0.42
Tax
36.45
19.75
-2.61
14.42
-125.43
0.27
0.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-99.56
41.95
15.91
41.98
145.52
-11.02
-0.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-99.56
41.95
15.91
41.98
145.52
-11.02
-0.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-99.56
41.95
15.91
41.98
145.52
-11.02
-0.47
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
778.35
870.13
775.01
730.41
619.69
354.94
321.23
Earnings per share (EPS)
-2.15
0.81
0.34
0.92
3.33
-0.27
-0.01
Diluted Earnings per share
-2.15
0.81
0.34
0.92
3.33
-0.27
-0.01
Operating Profit Margin (Excl OI)
13.92%
12.94%
10.64%
24.53%
11.99%
8.48%
7.29%
Gross Profit Margin
2.24%
20.34%
15.72%
15.69%
9.31%
2.1%
3.78%
PAT Margin
-14.2%
6.22%
2.39%
7.75%
33.87%
-2.62%
-0.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 3.85% vs 1.23% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -337.14% vs 164.15% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 8.29% vs 0.31% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -18.23% vs -49.25% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Pacira Biosciences, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
700.97
629.18
71.79
11.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
700.97
629.18
71.79
11.41%
Raw Material Cost
227.72
324.20
-96.48
-29.76%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
16.57
0.00
16.57
Selling and Distribution Expenses
294.10
218.94
75.16
34.33%
Other Expenses
6.50
6.45
0.05
0.78%
Total Expenditure (Excl Depreciation)
603.39
607.67
-4.28
-0.70%
Operating Profit (PBDIT) excl Other Income
97.57
21.51
76.06
353.60%
Other Income
19.32
61.16
-41.84
-68.41%
Operating Profit (PBDIT)
195.68
113.77
81.91
72.00%
Interest
16.57
0.00
16.57
Exceptional Items
-163.43
-0.02
-163.41
-817,050.00%
Gross Profit (PBDT)
473.25
304.98
168.27
55.17%
Depreciation
78.78
31.09
47.69
153.39%
Profit Before Tax
-63.11
82.67
-145.78
-176.34%
Tax
36.45
28.80
7.65
26.56%
Provisions and contingencies
0
0
0.00
Profit After Tax
-99.56
53.87
-153.43
-284.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-99.56
53.87
-153.43
-284.82%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-99.56
53.87
-153.43
-284.82%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
778.35
1,793.01
-1,014.66
-56.59%
Earnings per share (EPS)
-2.15
1.43
-3.58
-250.35%
Diluted Earnings per share
-2.15
1.43
-3.58
-250.35%
Operating Profit Margin (Excl OI)
13.92%
3.42%
0.00
10.50%
Gross Profit Margin
2.24%
18.08%
0.00
-15.84%
PAT Margin
-14.20%
8.56%
0.00
-22.76%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 70.10 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.85% vs 1.23% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -9.96 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -337.14% vs 164.15% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.64 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.29% vs 0.31% in Dec 2023

Annual - Interest
Interest 1.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -18.23% vs -49.25% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.92%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023